Skip to content

Transpulmonary Gradient After Cardiac Surgery Under Cardiopulmonary Bypass

Transpulmonary Gradient of Inflammation Biomarkers and Pulmonary Vascular Resistance in Acute Respiratory Failure After Cardiac Surgery Under Cardiopulmonary Bypass

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01723930
Enrollment
30
Registered
2012-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2012-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome After Cardiac Surgery Under Cardiopulmonary Bypass

Brief summary

Get a better understanding of the pathophysiological processes of acute respiratory failure following cardiopulmonary bypass to initiate timely therapies targeted on a cell line. Demonstrate that there is a relationship between increased transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistance on the one hand and alveolo-capillary gas exchange on the other hand after cardiac surgery under cardiopulmonary bypass.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient man or woman \> 18 y.o. * Patient has signed informed consent prior to the study * Patient affiliated to a social security administration * Patient operated on for cardiac surgery at the University Hospital of Strasbourg. * Patient at high risk for postoperative respiratory failure defined by a SLIP score (Kor et al.) ≥ 22 Kor: * High-risk cardiac intervention under cardiopulmonary bypass (19 pts) * COPD (10 pts) * Diabetes (6 pts) * gastroesophageal reflux (7 pts) * Alcohol abuse (11 pts) * Scheduled use of a pulmonary artery catheter and a left atrial catheter

Exclusion criteria

* Inability to obtain informed consent from the patient and / or unable to give informed patient information (difficulty understanding ...) * Urgent surgery (\<24h) * Acute heart failure * Patient ventilated preoperatively * Allergy to Latex * Persons deprived of liberty or under judicial protection * Patient placed under guardianship * Pregnancy * Breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistanceduring the surgeryDemonstrate that there is a relationship between increased transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistance on the one hand and alveolo-capillary gas exchange on the other hand after cardiac surgery under cardiopulmonary bypass.

Countries

France

Contacts

Primary ContactJulien POTTECHER, MD
julien.pottecher@chru-strasbourg.fr03 88 12 70 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026